Paul A. Sieving, MD PhD
Affiliations: | 1985-2001 | Ophthalmology | University of Michigan Medical School Ann Arbor |
2001-2019 | National Eye Institute, Bethesda, Maryland | ||
2019- | Ophthalmology | University of California, Davis, Davis, CA |
Area:
visual system, retina, genetics, retinal degeneration, gene therapy, Biomedical Engineering, Ophthalmology, Neuroscience BiologyGoogle:
"Paul Sieving"Bio:
Dr. Paul A. Sieving is an ophthalmologist with extensive expertise in inherited retinal diseases (“IRD”). He served as Director of the National Eye Institute at the National Institutes of Health for nearly 20 years where he led the research programs to advance national vision health. Dr. Sieving previously was the Paul R. Lichter Professor of Ophthalmic Genetics at the University of Michigan Medical School for 17 years and founded the Centre for Retinal and Macular Degeneration. Dr. Sieving received his M.D. from the University of Illinois where he trained in ophthalmology and obtained a Ph.D. in bioengineering. He has developed and led translational therapy programs for IRD conditions using human ocular gene therapy and neurotrophic factor implants. Dr. Sieving has received prestigious awards including the Società Oftalmologica Italiana Honorary Award in Ophthalmology in 2016. He holds elected membership in the National Academy of Medicine USA and also in the German National Academy of Science. Since leaving the NIH in 2019, he founded the new Centre for Ocular Regenerative Therapy at the University of California, Davis.
(Show less)
Mean distance: 18.28
Parents
Sign in to add mentorDavid Allan Bromley | grad student | 1970-1973 | Yale University Graduate School | |
Guido Calebresi | grad student | 1973-1974 | Yale Law School | |
(In the JD program) | ||||
Morton Goldberg | grad student | 1978-1982 | UIC College of Medicine | |
Roy H. Steinberg | grad student | 1981-1983 | UCSF School of Medicine | |
Eliot Berson | post-doc | 1983-1985 | Harvard - MEEI | |
Paul R. Lichter | research scientist | 1985-1985 | University of Michigan Medical School Ann Arbor |
Collaborators
Sign in to add collaboratorRadha Ayyagari | collaborator | UCSD Medical Center | |
J Bernard Heymann | collaborator | (Computational Biology Tree) | |
Laura Frishman | collaborator | 1982- | University of Houston College of Optometry |
Ronald A. Bush | collaborator | 1990- | NEI |
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ader M, Cursiefen C, Fauser S, et al. (2024) Ophthalmological research in Germany: suggestions by an international expert panel. Die Ophthalmologie |
Zeng Y, Gao S, Li Y, et al. (2024) OCT Intensity of the Region between Outer Retina Band 2 and Band 3 as a Biomarker for Retinal Degeneration and Therapy. Bioengineering (Basel, Switzerland). 11 |
Ader M, Cursiefen C, Fauser S, et al. (2024) [Ophthalmological research in Germany: evaluation by an international expert panel]. Die Ophthalmologie |
Fadda A, Martelli F, Zein WM, et al. (2024) Statistical Evaluation of ERG Responses: A New Method to Validate Cycle-by-Cycle Recordings in Advanced Retinal Degenerations. Investigative Ophthalmology & Visual Science. 65: 3 |
Wood EH, Moshfeghi DM, Capone A, et al. (2023) A Literary Pediatric Retina Fellowship With Michael T. Trese, MD. Ophthalmic Surgery, Lasers & Imaging Retina. 54: 701-712 |
Ku CA, Wei LW, Sieving PA. (2023) X-Linked Retinoschisis. Cold Spring Harbor Perspectives in Medicine |
Sin TN, Kim S, Li Y, et al. (2023) A Spontaneous Nonhuman Primate Model of Myopic Foveoschisis. Investigative Ophthalmology & Visual Science. 64: 18 |
Kiani AK, Pheby D, Henehan G, et al. (2022) Ethical considerations regarding animal experimentation. Journal of Preventive Medicine and Hygiene. 63: E255-E266 |
Kiani AK, Naureen Z, Pheby D, et al. (2022) Methodology for clinical research. Journal of Preventive Medicine and Hygiene. 63: E267-E278 |
Heymann JB, Vijayasarathy C, Fariss RN, et al. (2022) Advances in understanding the molecular structure of retinoschisin while questions remain of biological function. Progress in Retinal and Eye Research. 101147 |